Точки приложения противовирусной терапии хронической HBV-инфекции у беременных
Аннотация
Ключевые слова
Об авторах
П. О. БогомоловРоссия
М. В. Мациевич
Россия
Н. В. Воронкова
Россия
О. С. Кузьмина
Россия
Список литературы
1. Alimenti A., Burdge D.R., Ogilvie G.S. [et al.] Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy // Pediatr. Infect. Dis. J. 2003. Vol. 22, No. 9. P. 782-789.
2. Antiviral Pregnancy Registry (APR). Antiviral Pregnancy Registry Interim Report 1, January 1989 through 31 January 2012. URL: http://APregistry.com2012 (дата обращения: 01.11.2012).
3. Beasley R.P, Stevens C.E., Shiao I.S., Meng H.C. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B // Lancet. 1975. Vol. 2 (7938). P. 740-741.
4. Burk R.D., Hwang L.Y., Ho G.Y. [et al.] Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load // J. Infect. Dis. 1994. Vol. 170, No. 6. P. 1418-1423.
5. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection // J. Hepatol. 2012. Vol. 57, No. 1. P. 167-185.
6. Gambarin-Gelwan M. Hepatitis B in pregnancy // Clin. Liver Dis. 2007. Vol. 11, No. 4. P 945-963.
7. Gibb D.M., Kizito H., Russell E.C. [et al.] DART trial team. Pregnancy and infant outcomes among HIV-infected women taking long-term ARTwithandwithout tenofovir in the DART trial // PLoSMed. 2012. Vol. 9, No. 5. P e1001217.
8. Han G.R., Cao M.K., Zhao W. [et al.] A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection // J. Hepatol. 2011. Vol. 55, No. 6. P. 1215-1221.
9. Han G.R., Jiang X.H., Zhao W. [et al.] Lamivudine use in the 2nd or 3rd trimester of pregnancy has similar efficacy in preventing vertical transmission of chronic hepatitis B in highly viremic mothers // Hepatology. 2011. Vol. 54 (S4). P 479A.
10. Hill J.B., Sheffield J.S., Kim M.J. [et al.] Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers // Obstet. Gynecol. 2002. Vol. 99, No. 6. P. 1049-1052.
11. Lin H.H., Wu WY., Kao J.H., Chen D.S. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics // J. Gastroenterol. Hepatol. 2006. Vol. 21, No. 3. P. 605-609.
12. Lok A.S.F., McMahon B.J. Chronic hepatitis B: update 2009 // Hepatology. 2009. Vol. 50, No. 3. P. 661-662.
13. Pan C., Zhang H., Pang Q. [et al.] Real world data on the efficacy and safety of telbivudine or lamivudine use in late pregnancy for the prevention of perinatal transmission of hepatitis B virus to the infants // Hepatology. 2012. Vol. 56 (S1). P. 368A.
14. Pan C.Q., Duan Z.P, Bhamidimarri K.R. [et al.] An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus // Clin. Gastroenterol. Hepatol. 2012. Vol. 10, No. 5. P. 452-459.
15. Pan C.Q., Han G.R., Jiang H.X. [et al.] Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B // Clin. Gastroenterol. Hepatol. 2012. Vol. 10, No. 5. P. 520-526.
16. Pan C.Q., Mi L.J., Bunchorntavakul C. [et al.] Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series // Dig. Dis. Sci. 2012. Vol. 57, No. 9. P 2423-2429.
17. Shah I. Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy // Ann. Trop. Paediatr. 2009. Vol. 29, No. 4. P. 257-261.
18. Shaheen A.A., Myers R.P. The outcomes of pregnancy in patients with cirrhosis: a population-based study // Liver Int. 2010. Vol. 30, No. 2. P. 275-283.
19. Söderström A., Norkrans G., Lindh M. Hepatitis B virus DNA
20. Тихоокеанский медицинский журнал, 2015, № 3 during pregnancy and postpartum: aspects on vertical transmission // Scand. J. Infect. Dis. 2003. Vol. 35, No. 11-12. P. 814-819.
21. Tan H.H., Lui H.F., Chow W.C. Chronic hepatitis B virus (HBV) infection in pregnancy. // Hepatol. Int. 2008. Vol. 2, No. 3. P. 370-375.
22. Ter Borg M.J., Leemans W.F., de Man R.A., Janssen H.L. Exacerbation of chronic hepatitis B infection after delivery // J. Viral. Hepat. 2008. Vol. 15, No. 1. P. 37-41.
23. Van Rompay K.K., Hamilton M., Kearney B., Bischofberger N. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques // Antimicrob. Agents Chemother. 2005. Vol. 49, No. 5. P. 2093-2094.
24. Weinbaum C.M., Williams I., Mast E.E. [et al.] Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection // MMWR Recomm. Rep. 2008. Vol. 57 (RR-8). P. 1-20.
25. Wiseman E., Fraser M.A., Holden S. [et al.] Perinatal transmission of hepatitis B virus: an Australian experience // Med. J. Aust. 2009. Vol. 190, No. 9. P. 489-492.
26. World Health Organization. Hepatitis B Fact sheet, July 2012. URL: http://www.who.int/mediacentre/factsheets/fs204/ en (дата обращения: 01.11.2012).
27. Xu D.Z., Yan Y.P, Choi B.C. [et al.] Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study // J. Med. Virol. 2002. Vol. 67, No. 1. P. 20-26.
28. Xu WM., Cui Y.T., Wang L. [et al.] Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study // J. Viral. Hepat. 2009. Vol. 16, No. 2. P 94-103.
29. Yang Y.B., Li X.M., Shi Z.J., Ma L. Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: a case report // World J. Gastroenterol. 2004. Vol. 10, No. 15. P. 2305-2306.
30. Zou H., Chen Y., Duan Z. [et al.] Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers // J. Viral. Hepat. 2012. Vol. 19, No. 2. P. e18-e25.
Рецензия
Для цитирования:
Богомолов П.О., Мациевич М.В., Воронкова Н.В., Кузьмина О.С. Точки приложения противовирусной терапии хронической HBV-инфекции у беременных. Тихоокеанский медицинский журнал. 2015;(3):22-25.
For citation:
Bogomolov P.O., Matsievich M.V., Voronkova N.V., Kuzmina O.S. Antiviral therapy for chronic HBV during pregnancy. Pacific Medical Journal. 2015;(3):22-25. (In Russ.)